Takashi Wada

机构：Kanazawa University, FIND · ORCID：0000-0002-0123-3645

发表论文 811 篇 · 总被引 21144 次 · h-index 71

代表论文

• Clinically meaningful eGFR slope as a surrogate endpoint differs across CKD stages and slope evaluation periods: the CKD-JAC study (2025 · Clinical Kidney Journal · 被引 13)
• A randomized, open-label, clinical trial examined the effects of canagliflozin on albuminuria and eGFR decline using an individual pre-intervention eGFR slope (2024 · Kidney International · 被引 10)
• Urinary D-asparagine level is decreased by the presence of glioblastoma (2024 · Acta Neuropathologica Communications · 被引 8)
• Efficacy and Safety of Finerenone in Asian Patients with Type 2 Diabetes and Chronic Kidney Disease: A FIDELITY Analysis (2025 · Kidney Diseases · 被引 7)
• Canagliflozin and iron metabolism in the CREDENCE trial (2024 · Nephrology Dialysis Transplantation · 被引 6)
• Finerenone in Patients With Chronic Kidney Disease Due to Glomerular Diseases (2026 · JAMA · 被引 5)